Author

@StonkValue StonkValue

Perma-bull retail thematic-basket builder riding the early AI-infrastructure buildout

Publishes long-horizon, sector-organized baskets of small/mi

trader score
-1.74
hit rate
25%
mean α
-1.39%
signals 14d
118

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 25% hit rate, -1.39% mean alpha, trader score -1.74. Their last-14d mentions, direction-adjusted, have moved -10.2% since posting (mean over 87 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-28SEDG@StonkValue+0.30Includes SEDG in a solar, storage and energy-management investment basket.
2026-08-28POWL@StonkValue+0.45Presents POWL as a power-infrastructure beneficiary with 9% growth and $2.4B backlog.
2026-08-28TSLA@StonkValue+0.45Frames TSLA as an energy-storage, EV and AI-infrastructure play with 26% revenue growth.
2026-08-28AMSC@StonkValue+0.35Includes AMSC as a grid-reliability and power-control infrastructure investment theme.·
2026-08-28HUBB@StonkValue+0.30Includes HUBB as a U.S. transmission and substation-equipment supplier.·
2026-08-28ENPH@StonkValue+0.30Includes ENPH in a distributed solar and energy-storage investment basket.
2026-08-28GEV@StonkValue+0.40Frames GEV as a beneficiary of rising electricity demand from AI data centers and electrification.
2026-08-28ETN@StonkValue+0.50Presents ETN as an AI data-center power play with record $8.5B quarterly sales.
2026-08-28TE@StonkValue+0.55Argues a new U.S. transformer and grid-equipment restriction creates an investment theme benefiting TE.
2026-08-28EOSE@StonkValue+0.50Presents EOSE as a U.S.-made long-duration storage play with $68.8M revenue and 351% growth.
2026-08-28MXL@StonkValue+0.35Includes MXL as an AI optical-connectivity and semiconductor-infrastructure play.
2026-08-28DELL@StonkValue+0.50Presents DELL as an AI-server play with record $43.8B revenue and 88% growth.
2026-08-28ABCL@StonkValue+0.30Includes ABCL as an antibody-discovery and drug-development platform play.
2026-08-28TXG@StonkValue+0.35Includes TXG as a genomics play and cites Q2 revenue of $151M.
2026-08-28IBRX@StonkValue+0.30Includes IBRX as a cancer-immunotherapy and commercial-biotech investment play.

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.